Enzymotec Priced, Nasdaq: ENZY
Develops lipid-based nutritional ingredients and medical foods.
Industry: Health Care
First Day Return: +29.7%
ENZY
Develops lipid-based nutritional ingredients and medical foods.
| IPO Data | |
|---|---|
| IPO Date | 09/26/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $62 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Migdal Ha'Emeq, Israel |
| Founded | 1998 |
| Employees at IPO | 158 |
| Website www.enzymotec.com | |
IPO News for Enzymotec
Enzymotec (ENZY) Performance
